FDA Approves Imlunestrant (Inluriyo) for Certain Hormone Receptor-Positive Breast Cancers

moderators Posts: 10,640

September 2025 in Hormonal Therapy - Before, During, and After

Imlunestrant is a hormonal therapy medicine used to treat advanced-stage hormone receptor-positive breast cancer that grew during treatment with other hormonal therapy medicines.

Read our breaking news article.

Tagged:

• ER-positive
• PR-positive
• imlunestrant (Inluriyo)

0

Comments

• 

  greatly blessed Posts: 54

  October 12

  Does anyone know anything about Inluriyo?

  0